GlassScriptPhysician profile
Tania C Edwards
NPI 1598768145
$696.78
in general payments reported to CMS, 2019-2025
16 companies · $46.43 in 2025
The $46.43 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $173 · 2021: $48.89 · 2022: $51.51 · 2023: $13.40 · 2024: $165 · 2025: $46.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $224.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $128.67 | 2024 | |
| Lilly USA, LLC | $121.26 | 2020-2022 | |
| Amag Pharmaceuticals, INC. | $103.57 | 2019 | |
| Pfizer INC. | $55.64 | 2019-2025 | |
| Exact Sciences Corporation | $44.40 | 2024-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $37.15 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $31.91 | 2019-2020 | |
| Amgen INC. | $27.74 | 2020 | |
| Novartis Pharmaceuticals Corporation | $27.46 | 2022-2023 | |
| Glaxosmithkline, LLC. | $21.30 | 2024 | Bexsero, Shingrix, Arexvy |
| Abbvie INC. | $20.06 | 2022 | |
| Supernus Pharmaceuticals, INC. | $19.69 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.53 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.84 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.80 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $12.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tania Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.